Drug-Resistant TB Underdiagnosed

At least three-quarters of drug-resistant tuberculosis cases have not been detected, according to the World Health Organization.

Written byKerry Grens
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, YALE ROSENThe World Health Organization's latest Global Tuberculosis Report is a mix of good and bad news. On the bright side, the rate of new tuberculosis (TB) cases and the percentage of people who die from the disease has continued to decline. Although 8.6 million people developed TB in 2013 and 1.3 million died from it, the mortality rate is almost half of what it was in 1990. Still, “the debt toll of tuberculosis, a disease that is preventable and curable, is far too high,” Mario Raviglione, director of the WHO Global TB program, told reporters.

The bad news, according to WHO's report, is that multi-drug resistant TB cases are largely flying under the radar. Less than 25 percent of drug resistant cases have been detected in 2012. In a statement, Grania Brigden, the TB Advisor for Doctors Without Borders, said that improved diagnostic technology has greatly improved doctors' ability to detect cases. But “with three in four people with [drug resistant]-TB still not properly diagnosed, and 17,000 of those diagnosed not started on treatment, we are still very far away from making real progress against this killer disease.”

According to Reuters, Raviglione said that limited resources are a hurdle to getting more people diagnosed and treated. Furthermore, “we have patients diagnosed but not enough drug supplies or trained people to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Accelerating Recombinase Reprogramming with Machine Learning

Accelerating Recombinase Reprogramming with Machine Learning

Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo

Products

waters-logo

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

zymo-research-logo

Zymo Research Partners with Harvard University to Bring the BioFestival to Cambridge, Empowering World-class Research

10x-genomics-logo

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA